Remogliflozin etabonate, a selective inhibitor of the sodium-glucose transporter 2, improves serum glucose profiles in type 1 diabetes (Q34301921)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Remogliflozin etabonate, a selective inhibitor of the sodium-glucose transporter 2, improves serum glucose profiles in type 1 diabetes |
scientific article |
Statements
1 reference
Remogliflozin etabonate, a selective inhibitor of the sodium-glucose transporter 2, improves serum glucose profiles in type 1 diabetes (English)
1 reference
Sunder Mudaliar
1 reference
Debra A Armstrong
1 reference
Annie A Mavian
1 reference
Robin O'Connor-Semmes
1 reference
Patricia K Mydlow
1 reference
June Ye
1 reference
Elizabeth K Hussey
1 reference
Derek J Nunez
1 reference
Robert R Henry
1 reference
Robert L Dobbins
1 reference
25 September 2012
1 reference
1 reference
Identifiers
1 reference